Tue, February 22, 2011
[ Tue, Feb 22nd 2011 ] - Market Wire
PROTOX APPOINTS NEW DIRECTORS
Mon, February 21, 2011
Sun, February 20, 2011
Fri, February 18, 2011
Thu, February 17, 2011
Wed, February 16, 2011
Tue, February 15, 2011
Mon, February 14, 2011
Fri, February 11, 2011
Thu, February 10, 2011
Wed, February 9, 2011
Tue, February 8, 2011
Mon, February 7, 2011
[ Mon, Feb 07th 2011 ] - Market Wire
00 A.M. EST
Sun, February 6, 2011
Fri, February 4, 2011
Thu, February 3, 2011

Geron to Present at 13th Annual BIO CEO & Investor Conference


//health-fitness.news-articles.net/content/2011/ .. -at-13th-annual-bio-ceo-investor-conference.html
Published in Health and Fitness on Monday, February 14th 2011 at 1:21 GMT by Market Wire   Print publication without navigation


MENLO PARK, Calif.--([ BUSINESS WIRE ])--Geron Corporation (NASDAQ:GERN) today announced that David L. Greenwood, president and chief executive officer, will present an update of the company at 11:30 a.m. ET on Tuesday, February 15, 2011, at the 13th Annual BIO CEO & Investor Conference in New York City.

The webcast for the live audio and slide presentation will be available at [ http://www.veracast.com/webcasts/bio/ceoinvestor2011/84208505.cfm ]. The presentation will be archived for replay and available at the same address one hour after conclusion of the live event for a period of 30 days.

About Geron

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. The company is advancing anti-cancer therapies through multiple Phase 2 clinical trials in different cancers by targeting the enzyme telomerase and with a compound designed to penetrate the blood-brain barrier. The company is developing cell therapy products from differentiated human embryonic stem cells for multiple indications, including central nervous system (CNS) disorders, heart failure, diabetes and osteoarthritis, and has initiated a Phase 1 clinical trial in spinal cord injury. For more information, visit [ www.geron.com ].


Publication Contributing Sources